𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia

✍ Scribed by Lalit Kumar; V. Kochupillai; Harsch Dua


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
408 KB
Volume
63
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


High dose cytosine arabinoside (HDARAC)
✍ Seth A. Rudnick; Edwin C. Cadman; Robert L. Capizzi; Roland T. Skeel; Joseph R. πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 415 KB πŸ‘ 2 views

Thirteen leukemic patients with disease refractory to conventional chemotherapy were treated with 1.0 to 7.5 g/m2 of Cytosine Arabinoside (Ara-C) over 29 drug cycles. Drug infusions were spaced at 12-hour intervals; a maximum of four doses was administered over 36 hours. After single dose tolerance

Low-dose cytosine arabinoside in the mye
✍ J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 351 KB πŸ‘ 1 views

Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre

Cytosine arabinoside in acute leukemia o
✍ D. G. Traggis; A. Dohlwitz; L. Das; N. Jaffe; W. C. Moloney; T. C. Hall πŸ“‚ Article πŸ“… 1971 πŸ› John Wiley and Sons 🌐 English βš– 304 KB πŸ‘ 2 views